Formosa Pharmaceuticals has signed an exclusive licensing agreement with Cipla for the commercializa...

Bausch + Lomb has announced the U.S. launch of Arise, an advanced lens fitting system that leverages...

OSRX is expanding its pharmaceutical offerings with new medication sizes and direct-to-patient post-...

Nicox has announced the completion of data collection for the Whistler Phase 3b clinical trial inves...

HanAll Biopharma has received Orphan Drug Designation (ODD) from the Ministry of Health, Labor and W...

Iantrek Corporation has released promising results from its two-year clinical study on bio-reinforce...

China has approved SYCUME, the country’s first monoclonal antibody treatment for thyroid eye disease...

Stealth BioTherapeutics Inc. has achieved 50% of its enrollment target in the global Phase 3 ReNEW s...

Harrow, a North American eyecare pharmaceuticals company, has introduced VEVYE Access For All, a new...

...